11 – 20 of 134
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)—A Summary of the 2024 Guidelines Update
- Contribution to journal › Scientific review
-
Mark
Distinct Infiltration of T Cell Populations in Bladder Cancer Molecular Subtypes
- Contribution to journal › Article
-
Mark
Similar immune responses to alpha1-oleate and Bacillus Calmette–Guérin treatment in patients with bladder cancer
- Contribution to journal › Article
-
Mark
Sex bias in FGFR3 somatic mutations in bladder cancer
- Contribution to journal › Article
-
Mark
International Society of Urological Pathology Consensus Conference on Current Issues in Bladder Cancer. Working Group 4: Molecular Subtypes of Bladder Cancer - Principles of Classification and Emerging Clinical Utility
- Contribution to journal › Article
- 2023
-
Mark
Predictive value of molecular subtypes and APOBEC3G for adjuvant chemotherapy in urothelial bladder cancer
- Contribution to journal › Article
-
Mark
Women’s experience of sexuality after radical cystectomy–a qualitative study
- Contribution to journal › Article
-
Mark
The Lund taxonomy for bladder cancer classification – from gene expression clustering to cancer cell molecular phenotypes, and back again
- Contribution to journal › Scientific review
-
Mark
UROSCAN and UROSCANSEQ : a large-scale multicenter effort towards translation of molecular bladder cancer subtypes into clinical practice–from biobank to RNA-sequencing in real time
- Contribution to journal › Article
-
Mark
FDG-PET/CT for lymph node staging prior to radical cystectomy
- Contribution to journal › Article
